Rexahn Pharmaceuticals, Inc. (RNN)

0.26
-0.0061 (-2.2932%)
Exchange
ASE
Day Range
0.2580 - 0.2650
52 Week Range
0.2500 - 0.6900
Open
0.2604
Avg. Vol
603,858
Market Cap
55.40M
Short ratio
2.2400
PEG Ratio
0.0000
Earnings Share
-0.0760
Bid
0.2583
Book Value
0.0810
EPS Current Year Estimate
-0.0900
EPS Estimate Next Year
0.0900
Change from Year Low
0.0099
Change from Year High
-0.4301
Price Target 1 Year
2.7500

Complete Profile

Name Rexahn Pharmaceuticals, Inc.
Sector Healthcare
Industry Biotechnology
Address

Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road
Suite 455
Rockville, MD 20850
United States - Map
Phone: 240-268-5300
Fax: 240-268-5310
Website: http://www.rexahn.com

Employees 22
Executives Dr. Peter D. Suzdak Ph.D.
Chief Exec. Officer and Director


Dr. Chang H. Ahn Ph.D.
Founder Chairman Emeritus and Director


Dr. Tae Heum Jeong D. Mgt.
Chief Financial Officer Sr. VP and Sec.


Dr. Ely Benaim M.D.
Chief Medical Officer


Dr. Reza Mazhari Ph.D.
VP of Translational Medicine


Holders
  • Vanguard Total Stock Market Index Fund
  • Vanguard Extended Market Index Fund
  • Spartan Extended Market Index Fund
  • Spartan Total Market Index Fund
  • Vanguard Balanced Index Fund
  • Quantitative Master Series Tr-Extended Market Index Series
  • Claymore ETF Tr-Wilshire Micro Cap ETF
  • iShares Core S&P Total U.S. Stock Market ETF
  • Philadelphia Investment Partners New Generation Fd